These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6348918)

  • 1. Immunization against measles by aerosol.
    Sabin AB
    Rev Infect Dis; 1983; 5(3):514-23. PubMed ID: 6348918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Sever JL; Madden DL; Shekarchi I; Albrecht P
    JAMA; 1983 May; 249(19):2651-62. PubMed ID: 6341638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
    Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.
    Low N; Kraemer S; Schneider M; Restrepo AM
    Vaccine; 2008 Jan; 26(3):383-98. PubMed ID: 18082295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against measles. The situation in Mexico and America. Advances in the method of aerosol immunization].
    Fernández de Castro J; Kumate J
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):449-61. PubMed ID: 2206410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative routes of measles immunization: a review.
    Cutts FT; Clements CJ; Bennett JV
    Biologicals; 1997 Sep; 25(3):323-38. PubMed ID: 9325001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.
    Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J
    Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles in Mexico.
    Fernandez de Castro J
    Rev Infect Dis; 1983; 5(3):422-6. PubMed ID: 6878993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences in mass prevention of measles by vaccination.
    Perkins FT
    Trans R Soc Trop Med Hyg; 1975; 69(1):24-5. PubMed ID: 1145714
    [No Abstract]   [Full Text] [Related]  

  • 17. Failures of protection by measles vaccine.
    Plotkin SA
    J Pediatr; 1973 May; 82(5):908-11. PubMed ID: 4698971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of an aerosolized vaccine against measles.
    Low N; Bavdekar A; Jeyaseelan L; Hirve S; Ramanathan K; Andrews NJ; Shaikh N; Jadi RS; Rajagopal A; Brown KE; Brown D; Fink JB; John O; Scott P; Riveros-Balta AX; Greco M; Dhere R; Kulkarni PS; Henao Restrepo AM
    N Engl J Med; 2015 Apr; 372(16):1519-29. PubMed ID: 25875257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles: summary of worldwide impact.
    Assaad F
    Rev Infect Dis; 1983; 5(3):452-9. PubMed ID: 6878998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.